Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements

BACKGROUND: When use of a single antiseizure medication (ASM) fails to induce seizure remission, add-on therapy is justified. Perampanel (PER) is approved in Europe as adjunctive therapy for focal, focal to bilateral tonic-clonic seizures and generalized tonic-clonic seizures. Aim of the study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonanni, Paolo, Gambardella, Antonio, Tinuper, Paolo, Acone, Benedetto, Perucca, Emilio, Coppola, Giangennaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549193/
https://www.ncbi.nlm.nih.gov/pubmed/34702211
http://dx.doi.org/10.1186/s12883-021-02450-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549193/
https://www.ncbi.nlm.nih.gov/pubmed/34702211
http://dx.doi.org/10.1186/s12883-021-02450-y

Ejemplares similares